A new Cancer Clinic in Sydney to include Regional NSW Hospital partnerships as well
$20 million to establish world-leading clinical trial centre for all NSW residents
A world-leading clinical trial centre in Sydney will soon provide increased access to international cancer clinical trials, thanks to a $20 million donation to the NORTH Foundation from philanthropists Greg Poche AO and the late Kay Van Norton Poche AO.
The NORTH Sydney Trials and Research Van Norton Poche (NORTH S.T.A.R VNP) is a partnership between Northern Sydney Local Health District (NSLHD) and world-renowned Memorial Sloan Kettering Cancer Center in New York.
NORTH S.T.A.R VNP will be located at the Sydney North Health Precinct, which includes Royal North Shore and North Shore Private hospitals, and will be available to all Australians, with regional NSW hospital partnerships also established.
The centre will also be used to attract the next generation of doctors, scientists and researchers to Australia and provide greater funding to discover cures through research and development.
Within months of the launch, the Centre will open four new studies including three clinical trials, providing access to new treatments for patients across metropolitan, regional and rural NSW.
https://www.health.nsw.gov.au/news/Pages/20240817_00.aspx
Comments
-
@gumnut There are already 4 trials going on at North Star VPN .... and one of them relates to circulating Tumour Cells in women with Breast Cancer ..... (see previous posts here re CTCs below - Circulating Tumour Cells.)
https://onlinenetwork.bcna.org.au/search?domain=all_content&query=circulating tumour cells&sort=-dateInserted&scope=site&source=community
I can see a day when this blood test will be a regular 'yearly check' for not only those already WITH any sort of cancer (to see if it has returned) - but also as a 'pre-cancer' determination as well.
THIS bit is of particular interest to Breast Cancer Patients ..... as it is now a trial at North Star VNP ....
QUOTE:- Improving breast cancer treatment for women who have residual disease, as determined by circulating tumour DNA, using a specialised blood test. This liquid biopsy technology-guided clinical trial is based on collaborative research between MSK and RNSH, which has resulted in multiple publications, including in leading journal Nature Medicine.
Read the whole article here (and keep an eye on this site for other trials in the future.)
https://northfoundation.org.au/media-release-launch-of-north-star-vnp/
There are some interesting BC stories here:
https://northfoundation.org.au/?s=breast+cancer
There are exciting things happening on the Trials Front - and hopefully, those with BC will directly benefit from these advances.
An interesting article on a clinical study in Melbourne re CTCs:
https://niim.com.au/research/ctc
0